ICAM1 and interstitial lung disease: Only one study having SSc-ILD as a primary endpoint so far has demonstrated that apart from EEVs, PEVs and leucocyte EVs (LEVs), EVs expressing either ICAM-1/TF were linked not only with the presence of ILD but also to the progression of lung disease.